The Importance of the Relationship Between the United Kingdom and India

Lord Browne of Ladyton Excerpts

Thursday 19th January 2023 Lords Chamber

[Lord Browne of Ladyton (Lab)]

My Lords, I thank the noble Baroness, Lady Verma, for securing this debate and congratulate her on her powerful and persuasive opening speech. She speaks truth to power very well.

It is a particular honour to follow my noble friend Lord Soley, who has sadly delivered his valedictory speech after over 43 years in Parliament—26 years in the other place and 17 years in this House. I say sadly because the whole House will miss his warmth, wisdom and judgment, so I invite the whole House to join me in thanking him for his service.

A probation officer, he was first elected for Hammersmith in 1979. He quickly became a significant figure in the parliamentary party, particularly on Northern Irish affairs, and consequently someone I came to admire well before I even met him. In 1997, the year I was first elected, beyond being re-elected, he was elected by his fellow Labour colleagues as chair of the Parliamentary Labour Party—an indication of the esteem in which he was held. Since then, it has been a real pleasure and an education to get to know him during our times together in both the other place and, subsequently, your Lordships’ House, which he joined in 2005 and I joined five years later.

I thank him for an informed and entertaining but characteristically modest speech. He has much to be proud of. I know he must be looking forward to his retirement, but he still has much to offer. He is still a crusader for more and better housing and education, civil liberties—although we now call them human rights—prison reform, Northern Ireland solutions, a responsible press and almost any other deserving cause. He is also an author, photographer and supporter of charity. Born in England, as he told us, he has chosen in his later life to live in Scotland, the wise man. There is a phrase in the Scottish cultural lexicon that perfectly fits Clive Soley and his experience of life: “a lad o’ pairts”, meaning

“a youth, particularly one from a humble background, who is considered talented or promising”.

Scotland prides itself on giving the lad o’ pairts opportunities for advancement. I am sure that he will seize them in his retirement.

In the time I have remaining, I turn to the subject of the debate. A UK-India FTA is currently under negotiation. We should remember that, in 2013, negotiations for the EU-India FTA collapsed due to concerns about the impact on India’s generic supply of and access to affordable medicines. The current negotiations appear to be in danger of foundering on the same rock. A recent leak from them revealed that the UK’s strategic position is to strengthen the position of multinational pharmaceutical corporations—many of which are based in the UK—at the expense of India’s public health safeguards, thus enabling companies to prolong their monopolies on medical products and charge higher prices for longer periods.

Presently, the UK, along with other countries around the world and providers such as Médecins Sans Frontières, relies heavily on access to affordable, quality-assured generic medicines, a large proportion of which are supplied by companies in India. Some 25% of the quality, affordable, generic medicines available on the NHS and a large proportion of medical products used by many low and middle-income countries are from Indian generics, including no less than 90% of generic medicines for HIV.

It seems rather counterintuitive that someone from these Benches needs to remind a Conservative Government of the basic principle of free trade: that having multiple independent generic suppliers for each medical product is important because the competition among them, and with the originator company, can bring prices down, enabling us better to serve public health needs and save more lives. However, this can happen only if generic companies are able to produce and supply more affordable medical products once the IP protection, including patents, on these products has expired or been removed.

The consequences of undermining India’s generic industry on supply and prices could be devastating for many countries with already stretched health budgets. This is of particular concern to LMICs, but it could also impact all countries that procure medicines from India, including the UK’s NHS. While the proposals in the leaked IP chapter of the UK-India FTA do not amount to a final negotiated chapter, they none the less point to the UK’s negotiating strategy—

[Baroness Williams of Trafford (Con)]

I remind the noble Lord that this is a time-limited debate. The only person we set that aside for was Lord Soley, because we had adjourned the House.

[Lord Browne of Ladyton (Lab)]

I have insufficient time to go into the detail of this issue, though I would love to, but I am fully briefed on it. I will happily meet and discuss this with other noble Lords, Ministers and officials if that is on offer.